Medication Maintenance Therapy in Community Pharmacy Settings

• Status: Completed
• Trial end date: 2018-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to examine how the pharmacy can better optimize treatment expansion by providing pharmacy-based medication assisted treatment (MAT) for maintenance under a collaborative pharmacy practice agreement.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Lifespan
• Collaborator: University of Rhode Island
• Treatments: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Naloxone; Naltrexone

Criteria

Inclusion Criteria:

• 18 years of age or older;

• English speaking; currently enrolled at a CODAC site in Rhode Island for the treatment of opioid use disorder;

• maintained on a stable dose of buprenorphine or injectable naltrexone for at least 2 days;

• no stable co-morbid illnesses likely to progress clinically during the pilot study;

• able and willing to provide written informed consent and locator information (working telephone and >2 contacts) to participate.

Exclusion Criteria:

• currently pregnant or trying to get pregnant;

• plans to move or leave the state during the study, including pending legal action;

• self reported past year suicide attempt or self-reported past year suicidal thoughts with a plan;

• any condition that, in the researchers' judgment, interferes with safe study participation or adherence to study procedures, including but not limited to a mental, medical or other substance use disorder that is likely to require ongoing, intense clinical management during the pilot study.